Robert is an experienced investment banking professional with more than 18 years of M&A and investment banking experience, primarily covering Emerging Markets. He has successfully completed more than €15bn in M&A and Capital Markets transactions over the past 15 years.
Prior to joining PharmaVentures, he held positions at Nomura International and KPMG and more recently at STJ Advisors (Capital Markets/IPO Advisory) and Goetz Partners (M&A) in London. Robert brings a strong track record in originating and executing M&A advisory and capital market transactions,
advising Western European/CEE/SEE and Asian investors (incl. private equity funds, family offices, SWFs and governments) around their acquisitions/investments, divestments and fundraising strategy (including equity and debt).
The appointment of Robert will enable PharmaVentures to strengthen our cross-border M&A and fundraising capabilities.